← All organizations

Tyme, Inc

For profitWebsite ↗

Also known as: Chief Medical Officer TYME Inc. | Tyme, Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Sep 22, 2021

Acquired by Syros Pharmaceuticals on Jul 6, 2022

Timeline

2010s

Jun 1, 2011
Tyme, Inc— Founded

2020s

Jul 6, 2022
Syros Pharmaceuticals— Acquired By

Drugs by trial phase (10 distinct, 5 trials)

Phase 2 (10 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

NCT04720664CollaboratorPhase 2Sep 22, 2021
NCT03778996CollaboratorPhase 2May 31, 2019
NCT03512756Study directorPhase 2Mar 27, 2018
NCT03512756Lead sponsorPhase 2Mar 27, 2018
NCT02562612Lead sponsorPhase 1/Phase 2Oct 1, 2016
NCT02796898Lead sponsorPhase 1/Phase 2Jun 1, 2016
NCT02796898Study directorPhase 1/Phase 2Jun 1, 2016

Details

Founded: New York, NY, US Jun 1, 2011
Last known activity: Sep 22, 2021